Management of patients with newly diagnosed malignant primary brain tumors with a focus on the evolving role of temozolomide

References

• AthanassiouHSynodinouMMaragoudakisERandomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiformeJ Clin Oncol2005232372715800329
   PubMed Web of Science ®Google Scholar
• CBTRUSStatistical report: primary brain tumors in the United States, 1998–20022005 Published by the Central Brain Tumor Registry of the United States
   Google Scholar
• CohenMHJohnsonJRPazdurRFood and Drug Administration Drug approval summary: temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiformeClin Cancer Res20051167677116203762
   PubMed Web of Science ®Google Scholar
• CombsSEGutweinSSchulz-ErtnerDTemozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II studyStrahlenther Onkol2005181372715925979
   PubMed Web of Science ®Google Scholar
• CurranWJJrScottCBHortonJRecursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trialsJ Natl Cancer Inst199385704108478956
   PubMed Web of Science ®Google Scholar
• FetellMRGrossmanSAFisherJDPreirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New Approaches to Brain Tumor Therapy Central Nervous System ConsortiumJ Clin Oncol199715312189294475
   PubMed Web of Science ®Google Scholar
• FineHADearKBLoefflerJSMeta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adultsCancer1993712585978453582
   PubMed Web of Science ®Google Scholar
• GilbertMRFriedmanHSKutteschJFA phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapyNeuro-oncol20024261712356356
   PubMed Web of Science ®Google Scholar
• GlantzMJColeBFForsythPAPractice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of NeurologyNeurology20005418869310822423
   PubMed Web of Science ®Google Scholar
• GreenSBByarDPWalkerMDComparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant gliomaCancer Treat Rep198367121326337710
   PubMedGoogle Scholar
• HildebrandJLecailleCPerennesJEpileptic seizures during follow-up of patients treated for primary brain tumorsNeurology2005652121516043788
   PubMed Web of Science ®Google Scholar
• LacroixMAbi-SaidDFourneyDRA multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survivalJ Neurosurg200195190811780887
   PubMed Web of Science ®Google Scholar
• MacdonaldDRKiebertGPradosMBenefit of temozolomide compared to procarbazine in treatment of glioblastoma multiforme at first relapse: effect on neurological functioning, performance status, and health related quality of lifeCancer Investigation2005231384415813507
   PubMed Web of Science ®Google Scholar
• MarrasLCGeertsWHPerryJRThe risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based reviewCancer200089640610931464
   PubMed Web of Science ®Google Scholar
• MehtaNSilverbergWRole of radiotherapy in the treatment of gliomasExpert Rev Neurother200556 SupplS516116274271
   PubMedGoogle Scholar
• MootsPLPitfalls in the management of patients with malignant gliomasSemin Neurol199818257659608622
   PubMed Web of Science ®Google Scholar
• [MRC] Medical Research Council Brain Tumor Working PartyRandomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trialJ Clin Oncol2001195091811208845
   PubMed Web of Science ®Google Scholar
• NewlandsESBlackledgeGRSlackJAPhase I trial of temozolomide (CCRG 81045: [MRC] and B 39831: NSC 362856)Br J Cancer199265287911739631
   PubMed Web of Science ®Google Scholar
• O’ReillySMNewlandsESGlaserMGTemozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumoursEur J Cancer199329A94028499146
   PubMed Web of Science ®Google Scholar
• StewartLAChemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trialsLancet200235910111811937180
   PubMed Web of Science ®Google Scholar
• StuppRDietrichPYOstermann KraljevicSPromising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomideJ Clin Oncol20022013758211870182
   PubMed Web of Science ®Google Scholar
• TolcherAWGersonSLDenisLMarked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedulesBr J Cancer20038810041112671695
   PubMed Web of Science ®Google Scholar
• VickNAPaleologosNAExternal beam radiotherapy: hard facts and painful realitiesJ Neurooncol1995249358523083
   PubMed Web of Science ®Google Scholar
• WalkerMDAlexanderEJrHuntWEEvaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trialJ Neurosurg19784933343355604
   PubMed Web of Science ®Google Scholar
• WalkerMDGreenSBByarDPRandomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgeryN Engl J Med1980303132397001230
   PubMed Web of Science ®Google Scholar
• WenPToonTSBlackPLawsEKayeAClinical imaging, and laboratory diagnosis of brain tumorsBrain tumors2001New YorkJones and Bartlett2450
   Google Scholar
• WickWSteinbachJPKukerWMOne week on/one week off: a novel active regimen of temozolomide for recurrent glioblastomaNeurology20046221131515184628
   PubMed Web of Science ®Google Scholar
• YungWKAlbrightREOlsonJA phase II study of temozolomide vs procarbazine in patients with glioblastoma multiforme at first relapseBr J Cancer2000835889310944597
   PubMed Web of Science ®Google Scholar
• YungWKPradosMDYaya-TurRMulticenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor GroupJ Clin Oncol19991727627110561351
   PubMed Web of Science ®Google Scholar